- Home
- ASRT vs BEAT Comparison
ASRT vs BEAT Comparison
Compare ASRT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- BEAT
- Stock Information
- Founded
- ASRT 1995
- BEAT 2015
- Country
- ASRT United States
- BEAT United States
- Employees
- ASRT N/A
- BEAT N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- ASRT Health Care
- BEAT Technology
- Exchange
- ASRT Nasdaq
- BEAT Nasdaq
- Market Cap
- ASRT 78.3M
- BEAT 65.1M
- IPO Year
- ASRT 1997
- BEAT 2021
- Fundamental
- Price
- ASRT $0.81
- BEAT $2.08
- Analyst Decision
- ASRT Strong Buy
- BEAT Buy
- Analyst Count
- ASRT 4
- BEAT 1
- Target Price
- ASRT $3.19
- BEAT $8.00
- AVG Volume (30 Days)
- ASRT 320.8K
- BEAT 132.5K
- Earning Date
- ASRT 03-10-2025
- BEAT 03-19-2025
- Dividend Yield
- ASRT N/A
- BEAT N/A
- EPS Growth
- ASRT N/A
- BEAT N/A
- EPS
- ASRT N/A
- BEAT N/A
- Revenue
- ASRT $125,763,000.00
- BEAT N/A
- Revenue This Year
- ASRT N/A
- BEAT N/A
- Revenue Next Year
- ASRT $1.84
- BEAT N/A
- P/E Ratio
- ASRT N/A
- BEAT N/A
- Revenue Growth
- ASRT N/A
- BEAT N/A
- 52 Week Low
- ASRT $0.73
- BEAT $1.35
- 52 Week High
- ASRT $1.80
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- ASRT 45.61
- BEAT 39.34
- Support Level
- ASRT $0.78
- BEAT $2.05
- Resistance Level
- ASRT $0.88
- BEAT $2.37
- Average True Range (ATR)
- ASRT 0.03
- BEAT 0.18
- MACD
- ASRT 0.00
- BEAT -0.02
- Stochastic Oscillator
- ASRT 32.80
- BEAT 21.24
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.